<?xml version="1.0" encoding="UTF-8"?>
<ref id="R18">
 <label>18.</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Platzbecker</surname>
   <given-names>U</given-names>
  </name>, 
  <name>
   <surname>Wermke</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Radke</surname>
   <given-names>J</given-names>
  </name>, 
  <etal/>
  <article-title>Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial</article-title>. 
  <source>Leukemia</source>. 
  <year>2012</year>;
  <volume>26</volume>:
  <fpage>381</fpage>â€“
  <lpage>389</lpage>.
  <pub-id pub-id-type="pmid">21886171</pub-id>
 </mixed-citation>
</ref>
